FTSE 100 down 0.1%, FTSE 250 down 0.4%
UK inflation unexpectedly rises in June
Diageo up after CEO steps down
Thursday's jobs data in focus
Updates with market closing prices
By Ankita Yadav
July 16 (Reuters) - UK stocks closed lower in volatile trade on Wednesday on investors' concerns over the U.S. Federal Reserve's independence, while investors awaited domestic employment data later in the week.
The blue-chip FTSE 100 .FTSE was down 0.1%, while the midcap FTSE 250 index .FTMC fell 0.4%.
Minutes before the UK stock market closed, a Bloomberg report said U.S. President Donald Trump is likely to fire Fed Chair Jerome Powell soon, pressuring Wall Street and the dollar, and causing a spike in Treasury yields. Trump later said he was not planning to do so.
Earlier in the day, the FTSE 100 was higher, shrugging off data showing an unexpected rise in Britain's annual rate of consumer price inflation to its highest in over a year at 3.6% in June.
All eyes will be on the employment and wages figures due on Thursday for hints on the Bank of England's next steps on interest rates.
"The market is more focussed on the jobs market because of recent commentary from Bank of England officials who suggested that they're more concerned about weakness in the labour market than in any spike in inflation, which they consider would be temporary," said Fiona Cincotta, senior market analyst at City Index.
The central bank is largely expected to cut interest rates by a quarter-point in August after recent economic data fuelled concerns of weaker domestic growth and a cooling labour market, but the chances of such a move dimmed after Wednesday's inflation data.
Among individual stocks, Diageo DGE.L added 0.5% after the world's biggest spirits maker announced the departure of CEO Debra Crew after two years on the job, with finance chief Nik Jhangiani taking over in the interim.
Rio Tinto RIO.L gained 1.2% after the mining giant reported its strongest second-quarter iron ore production since 2018, a day after promoting its iron ore chief Simon Trott to CEO.
AstraZeneca AZN.L edged 0.5% lower after the drugmaker's experimental therapy, anselamimab, failed to meet the main goal of a late-stage study for the treatment of AL amyloidosis, a rare condition that causes a buildup of protein deposits in the body.
(Reporting by Ankita Yadav in Bengaluru; Editing by Shinjini Ganguli and Chris Reese)
((Ankita.Yadav@thomsonreuters.com;))
For related prices, Reuters users may click on - * UK stock report .L FTSE index: 0#.FTS6 techMARK 100 index: .FTT1X FTSE futures: 0#FFI: Gilt futures: 0#FLG: Smallcap index: .FTSC FTSE 250 index: .FTMC FTSE 350 index: .FTLC Market digest: .AD.L Top 10 by vol: .AV.L Top price gainers: .NG.L Top % gainers: .PG.L Top price losers: .NL.L Top % losers: .PL.L * For related news, click on - * UK hot stocks: HOT and GB Wall Street: .N Gilts report: GB/ Euro bond report GVD/EUR Pan European stock report: .EU Tokyo stocks: .T HK stocks: .HK Sterling report: GBP/ Dollar report: USD/ * For company prices, click on - * Company directory: UKEQ By sector: FTAX * For pan-European market data, click on - * European Equities speed guide................ EUR/EQUITY FTSE Eurotop 300 index........................... .FTEU3 DJ STOXX index................................... .STOXX Top 10 STOXX sectors........................ .PGL.STOXXS Top 10 EUROSTOXX sectors................... .PGL.STOXXES Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S Top 25 European pct gainers.................... .PG.PEUR Top 25 European pct losers..................... .PL.PEUR
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.